Ea. Kallio et al., ROLE OF NITRIC-OXIDE IN EXPERIMENTAL OBLITERATIVE BRONCHIOLITIS (CHRONIC REJECTION) IN THE RAT, The Journal of clinical investigation, 100(12), 1997, pp. 2984-2994
The role of nitric oxide in obliterative bronchiolitis development, i.
e., chronic rejection, was investigated in the heterotopic rat trachea
l allograft model, An increase in the intragraft inducible nitric oxid
e synthase (iNOS) mRNA and mononuclear inflammatory cell iNOS immunore
activity was demonstrated during progressive loss of respiratory epith
elium and airway occlusion in nontreated allografts compared to syngen
eic grafts. In nontreated allografts, however, intragraft nitric oxide
production was decreased, most likely because of loss of iNOS epithel
ial expression, Treatment with aminoguanidine, a preferential inhibito
r of inducible nitric oxide synthase, was associated with enhanced pro
liferation of oc-smooth muscle actin immunoreactive cells and the inte
nsity of obliterative bronchiolitis early after transplantation, Amino
guanidine treatment did not affect iNOS mRNA synthesis or intragraft n
itric oxide production, but decreased iNOS immunoreactivity in smooth
muscle cells. Treatment with L-arginine, a precursor of nitric oxide,
significantly reduced obliterative changes. L.-arginine supplementatio
n enhanced intragraft iNOS mRNA synthesis and iNOS immunoreactivity in
capillary endothelial and smooth muscle cells as well as intragraft n
itric oxide production, Immunohistochemical analysis of allografts sho
wed that neither iNOS inhibition nor supplementation of the nitric oxi
de pathway affected the number of graft-infiltrating CD4+ and CD8+ T c
ells, ED1+ and ED3+ macrophages, immune activation with expression of
IL-2R or MHC class II, or production of macrophage or Th1 cytokines, I
n contrast, L-arginine treatment was associated with increased stainin
g for Th2 cytokines IL-4 and IL-10. In conclusion, this study demonstr
ates that nitric oxide has a protective role in obliterative bronchiol
itis development in this model, and suggests that nitric oxide either
directly or indirectly inhibits smooth muscle cell proliferation and m
odulates immune response towards Th2 cytokines.